Mar 15, 2018
70:69
For every 69 shares held, investors received 70. The price per share adjusted from $1.73 to $1.70.
The split itself did not change the total investment value.
DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B (NGM:DBP.B) operates in the Biotechnology industry.
DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B company overviewDOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B's most recent stock split was on March 15, 2018. It was a 70-for-69 forward split, so shareholders received 70 shares for every 69 they held.
DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B (NGM:DBP.B) has split its stock 2 times: a 83-for-81 split on May 18, 2016 and a 70-for-69 split on March 15, 2018.
DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B has split its stock 2 times. This history records 2 forward splits between May 18, 2016 and March 15, 2018.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B's 70-for-69 split on March 15, 2018, every 69 shares became 70 shares.
DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B has not announced a new split in our records. Its most recent split was on March 15, 2018, 8 years ago. Companies announce splits in advance, and any new NGM:DBP.B split will appear on this page.
Already premium?